Company / Return on Assets (ROA)
GeneDx Holdings Corp. Return on Assets (ROA) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-4.0%
FY2025
5-year range
-111.8% / -4.0%
FY2021-FY2025
Trend
+67.8%
vs FY2024
Sector context
#106 of 158
Health Care
What the data says
At -4.0%, GeneDx Holdings Corp.'s return on assets (roa) ranks #106 of 158 in the Health Care sector. Return on Assets (ROA) has increased for 3 consecutive years, from -111.8% in FY2022 to -4.0% in FY2025.
Based on SEC 10-K filings.
-4.0% in FY2025 with a 5-year CAGR of +91.9%.
Improved from -42.0% to -4.0% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +107.8pp
- 5-Year Change
- +91.9pp
- 10-Year Change
- -
Sector benchmark
#106 of 158 in Health CareTop 67% of 158This company -4.0% Sector average -2.2%
▼
-82.9% below sector average
Key checks
Key Insights
- GeneDx Holdings Corp.'s return on assets (roa) has grown for 3 consecutive years.
- In FY2025, return on assets (roa) increased 67.8% year-over-year.
- Currently 1.8pp below the Health Care sector average.
- Lowest return on assets (roa) in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -4.0% | +67.8% |
| FY2024 | -12.5% | +70.3% |
| FY2023 | -42.0% | +62.5% |
| FY2022 | -111.8% | -152.5% |
| FY2021 | -44.3% | +53.8% |
| FY2020 | -95.9% | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026